Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ofatumumab Induction and Maintenance in Elderly Patients With Poor Risk CLL in the Context of Allogeneic Transplantation(CLL-X4 Trial)

NCT01809847 is registered in ClinicalTrials.gov with Technische Universität Dresden as lead sponsor.

NCT NCT01809847
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01809847 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ofatumumab Induction and Maintenance in Elderly Patients With Poor Risk CLL in the Context of Allogeneic Transplantation(CLL-X4 Trial)
Lead sponsor
Technische Universität Dresden
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2013
Completion date
January 31, 2015
Enrollment
20 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lymphatic leukemia